ECVT trades 24.6% above Wall Street's consensus target of $9.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ECVT achieves its forward estimates and maintains a stable P/E multiple of 19.2x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Ecovyst Inc. (ECVT) has a Wall Street consensus price target of $9.67, based on estimates from 6 covering analysts. With the stock currently trading at $12.82, this represents a potential downside of -24.6%. The company has a market capitalization of $1.40B.
Analyst price targets range from a low of $9.00 to a high of $10.00, representing a 10% spread in expectations. The median target of $10.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ECVT trades at a trailing P/E of -21.0x and forward P/E of 19.2x. Analysts expect EPS to grow +218.0% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ASIXAdvanSix Inc. | $535M | $19.86 | $22.00 | +10.8% | Buy | 13.8x | 6 |
IOSPInnospec Inc. | $2.0B | $82.73 | $115.00 | +39.0% | Hold | 17.1x | 9 |
TROXTronox Holdings plc | $1.2B | $7.40 | $8.33 | +12.6% | Buy | — | 17 |
KWRQuaker Chemical Corporation | $2.6B | $150.18 | $176.75 | +17.7% | Buy | 21.4x | 14 |
HWKNHawkins, Inc. | $3.4B | $161.45 | — | — | Buy | 41.0x | 1 |
CODICompass Diversified | $761M | $10.11 | $15.00 | +48.4% | Hold | 35.8x | 14 |
ALBAlbemarle Corporation | $18.9B | $160.35 | $209.75 | +30.8% | Hold | 13.2x | 45 |
MEOHMethanex Corporation | $4.1B | $53.18 | $69.75 | +31.2% | Buy | 5.9x | 19 |
PSXPhillips 66 | $66.6B | $166.14 | $181.11 | +9.0% | Buy | 9.4x | 35 |
VLOValero Energy Corporation | $70.7B | $236.30 | $244.67 | +3.5% | Buy | 8.4x | 37 |
Quick answers to the most common questions about buying ECVT stock.
ECVT's consensus price target is $9.67, -24.6% below the current price of $12.82. The 6 analysts tracking ECVT see downside risk at present valuations.
ECVT has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $9.67 implies -24.6% downside from current levels.
With a forward P/E of 19.2117x, ECVT trades at a relatively low valuation. The consensus target of $9.67 implies -24.6% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $10 for ECVT, while the most conservative target is $9. The consensus of $9.67 represents the median expectation. These targets typically reflect 12-month expectations.
ECVT is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ECVT stock forecast based on 6 Wall Street analysts shows a consensus price target of $9.67, with estimates ranging from $9 (bear case) to $10 (bull case). The median consensus rating is "Buy".
ECVT trades at a forward P/E ratio of 19.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ECVT, with 0 Sell ratings and a price target of $9.67 (-24.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ECVT analyst price targets range from $9 to $10, a 10% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $9.67 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.